Variations in the ALOX5AP gene, which encodes arachidonate 5-lipoxygenase-activating protein, reportedly conferred an increased risk of myocardial infarction and stroke, independent of conventional risk factors [3], [4]. This evidence concerns the gene ALOX5AP and stroke disorder.